Navigation Links
Demand for DrugDev Spark™ Soars Among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
Date:9/12/2017

DrugDev, a QuintilesIMS company, continues to strengthen its position as the clinical technology provider for small to mid-size biotechs and pharma worldwide with continued adoption of the DrugDev Spark™ unified clinical trial suite.

Sponsors unfamiliar with DrugDev Spark can experience solutions for site selection and activation, eConsent, site payments and site engagement with hands-on technology demonstrations and best practice discussions at a series of educational “Clinical Coffee” events. Register here to attend the live session scheduled for September 27 from 9am-12pm ET in Parsippany, New Jersey.

DrugDev’s growth has come as a result of proven success improving clinical trials across therapeutic areas with sponsors of all sizes in addition to Top 20 global pharmaceutical clients.

Watch a rare disease webinar with Alnylam and AMO Pharma discussing how to use technology to design and conduct more efficient and effective clinical research.

“Clinical innovation isn’t reserved exclusively for Top 20 Pharma trying to build their brand as a sponsor of choice,” said DrugDev Chief Commercial Officer Brett Kleger. “Increasingly, smaller pharmas and biotechs are adopting DrugDev Spark to improve site relationships and productivity, elevate their CRO, and support internal study teams with efficient automation tools. Scalable technology like ours is flexible enough for any budget, and levels the playing field for smaller sponsors and biotechs worldwide.”

To learn how DrugDev Spark is changing the game for smaller pharmaceutical companies, begin a conversation or request a demo at http://www.drugdev.com.

About DrugDev
DrugDev, a QuintilesIMS company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on nearly 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14677792.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. AMRI’s Global Analytical Services Introduces Comprehensive Forced Degradation Services To Meet Pharmaceutical Industry Demand
2. Franz's Allegro Common Lisp Meets Demand for High Performance Artificial Intelligence and IoT Applications
3. Cannabis Companies Continue to Invest in Infrastructure and Grow Facilities to Keep up With Rising Demand
4. Nanobiotechnology - Global Strategic Business Report 2015-2022 - Demand for Novel Products to Push Up Growth - Research and Markets
5. SSCI Expands Biochemistry Services to Meet Growing Industry Demand
6. CohBar Inc. Presentation Now Available for On-Demand Viewing
7. SpineFrontier Enhances the MISquito Percutaneous Pedicle Screw System in Response to Growing Demand
8. Continuous Flow Chemistry Methods Revealed in On-Demand Webinars from METTLER TOLEDO
9. Demand of Amyloglucosidase Market to 2020 Analysed with Sales, Manufacture Share and Type
10. Chi-Med webcast presentation now available for on-demand viewing: Deutsche Bank ADR Virtual Investor Conference
11. Global Biomaterials Market - By Type, Application, Regions - Market Size, Demand Forecasts, Industry Trends and Updates (2014- 2020)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/9/2019)... ... 09, 2019 , ... The American Society of Gene & Cell Therapy ... including a new addition to the presidential line of succession, at the 22nd ... Society's leadership team for a three-year term (2019-2021). , All five incoming members of ...
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive ... dialogue, today announces its Boston CEO conference to be held May 28-29, 2019 ... and opportunities with high-level panels and discussions from past, present and future change-makers. ...
(Date:3/23/2019)... ... March 22, 2019 , ... uBiome has awarded microbiome ... of researchers at Nnamdi Azikiwe University in Anambra State, Nigeria led by Dr. ... the Department of Medical Laboratory Sciences and Deputy Provost, College of Health Sciences. ...
(Date:3/19/2019)... ... March 19, 2019 , ... Konica ... today announced the formation of their inaugural Scientific Advisory Board. , ... that takes into account individual variability in genes, environment, and lifestyle to more ...
Breaking Biology Technology:
(Date:4/4/2019)... ... April 03, 2019 , ... R3 Stem ... at its nationwide Centers of Excellence. R3 wants patients to feel secure when ... To protect patients from Centers that use inferior regenerative biologics, protocols or amounts, ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the wake ... programme entirely dedicated to Chinese biobanks was launched in July 2018, in an ... the Biobank Branch, China Medicinal Biotech Association (BBCMBA). The one-year pilot programme offered ...
(Date:3/27/2019)... ... 2019 , ... Evan Holden , a shareholder in the Atlanta ... at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA), ... firm’s award-winning Pharmaceutical, Medical Device & Health Care Litigation Practice , addressed, “Medical ...
Breaking Biology News(10 mins):